Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
CoreWeave Confronts Legal Deadline Ahead of Q4 Earnings Report
CoreWeave navigates a securities lawsuit deadline while investors await quarterly results. Shares closed at $96.04 ahead of the Washington's Birthday market holiday.
UnitedHealth Rallies Ahead of Key Medicare Decision
UnitedHealth Group shares closed 3.1% higher at $293.19 on Friday, marking a three-day rally. Investors are now focused on the upcoming final 2027 Medicare Advantage rate decision.
Goldman Sachs Legal Chief's Exit Amid Epstein Ties Rattles Market
Goldman Sachs shares closed flat at $905.14 after the bank's top lawyer said she would retire in June, with Justice Department documents revealing she accepted gifts from Jeffrey Epstein. Markets head into a holiday-shortened week after major indexes posted their largest weekly declines since November.
Lilly's $1.5B Oral Obesity Pill Stockpile Signals Major Launch Ambitions
Eli Lilly has accumulated $1.5 billion in pre-launch inventory for its experimental oral obesity treatment orforglipron, with the FDA's target decision date set for April 10. The substantial stockpile highlights the company's push to overcome supply limitations that have hampered the GLP-1 market.
P&G Shares Dip Amid Italy Ad Probe, Insider Sale Ahead of Dividend
Procter & Gamble shares declined 0.7% to $160.07 amid an Italian advertising investigation and an insider stock sale, with the company's quarterly dividend scheduled for payment.
Goldman Sachs Legal Chief Exits Amid Epstein Scandal Fallout
Goldman Sachs' top lawyer Kathy Ruemmler steps down following disclosures about her past interactions with Jeffrey Epstein, as the bank's shares face volatility.
Eli Lilly Builds $1.5B Inventory for Obesity Pill Ahead of FDA Decision
Eli Lilly shares edged higher Friday as the company disclosed a $1.5 billion inventory build for its experimental weight-loss pill orforglipron, awaiting an FDA decision this spring.
Visa Shares Drop on Legal Fee Disclosure, Stock Exchange Plan
Visa shares declined 3.1% Friday following a regulatory disclosure that ties a proposed Class B stock exchange to a significant reduction in legal interchange fees. The company estimates those fees at $39.4 billion as of October 2025.
Ex-CEO Gets 20 Years for $200M Bitcoin Ponzi Scheme
Former Praetorian Group International CEO Ramil Palafox received a 20-year prison sentence for orchestrating a $200 million Bitcoin Ponzi scheme that defrauded investors worldwide.